Group One Trading
CORT icon

Group One Trading’s Corcept Therapeutics CORT Stock Holding History

Group One Trading’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.58M Buy
+39,186
New +$1.47M ﹤0.01% 2288
2023
Q1 		– Sell
-7,828
Closed -$172K – 7309
2022
Q4 		$159K Buy
+7,828
New +$196K ﹤0.01% 4048
2021
Q3 		– Sell
-2,764
Closed -$57.8K – 8236
2021
Q2 		$61K Buy
+2,764
New +$61.5K ﹤0.01% 6406
2020
Q2 		– Sell
-7,437
Closed -$104K – 5827
2020
Q1 		$88K Buy
+7,437
New +$92K ﹤0.01% 3387
2019
Q4 		– Sell
-20,701
Closed -$288K – 5167
2019
Q3 		$293K Buy
+20,701
New +$254K ﹤0.01% 2785
2019
Q2 		– Sell
-41,937
Closed -$467K – 5009
2019
Q1 		$492K Buy
+41,937
New +$521K 0.01% 1954
2018
Q2 		– Sell
-19,429
Closed -$338K – 5142
2018
Q1 		$320K Buy
+19,429
New +$360K ﹤0.01% 2395
2017
Q3 		– Sell
-6,926
Closed -$103K – 4867
2017
Q2 		$82K Buy
+6,926
New +$75.3K ﹤0.01% 3238
2016
Q3 		– Sell
-7,699
Closed -$44.8K – 4583
2016
Q2 		$42K Sell
7,699
-4,605
-37% -$24K ﹤0.01% 3409
2016
Q1 		$58K Buy
12,304
+6,000
+95% +$23.4K ﹤0.01% 3176
2015
Q4 		$31K Buy
6,304
+5,968
+1,776% +$26.9K ﹤0.01% 3691
2015
Q3 		$1K Sell
336
-6,300
-95% -$32K ﹤0.01% 4751
2015
Q2 		$40K Buy
6,636
+2,536
+62% +$15.5K ﹤0.01% 3673
2015
Q1 		$23K Buy
4,100
+3,400
+486% +$12.3K ﹤0.01% 3814
2014
Q4 		$2K Sell
700
-5,893
-89% -$18K ﹤0.01% 4680
2014
Q3 		$18K Sell
6,593
-16,516
-71% -$43.7K ﹤0.01% 4164
2014
Q2 		$65K Sell
23,109
-21,529
-48% -$63.5K ﹤0.01% 3357
2014
Q1 		$195K Buy
+44,638
New +$156K ﹤0.01% 2461

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Group One Trading's CORT Position: Q1 2026 in Review

Group One Trading opened a new position in Corcept Therapeutics (CORT) in Q1 2026: 39,186 shares worth $1.58M. The stake represents ﹤0.01% of the portfolio and ranks #2288 among its holdings. This is a return to the name: Group One Trading previously reported a position in CORT as recently as Q4 2022.

Group One Trading first reported a position in CORT in Q1 2014 and has held it in 18 quarters since. 351 funds tracked by Wall St. Rank hold CORT as of Q1 2026.

  • Group One Trading held 39,186 shares of Corcept Therapeutics worth $1.58M as of Q1 2026.
  • Corcept Therapeutics was a new Group One Trading position in Q1 2026.
  • Corcept Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #2288 holding.
  • Group One Trading first reported a position in Corcept Therapeutics in Q1 2014 and has held it in 18 quarters since.
  • 351 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.